Auriga Partners is a Paris, France based venture capital investment firm that prefers to invest in companies operating in the information technology, communication technology and life sciences sectors. The firm was founded in 1998.
Auriga Partners has made investments in Exeliom, Flash Therapeutics, EnobraQ, Pherecydes Pharma, aveni, Vectalys, VitaDX, Nosopharm, TxCell, One More Company, Nexthink, Pylote and CoLucid Pharmaceuticals.
Auriga Partners raised their Auriga IV Bioseeds fund for a total of €42.3 million. This fund was announced on Nov 19, 2013.
A biopharmaceutical company developing T cell vaccines and immunotherapies
Biotech company that develops and commercializes ingredients for use in food, nutrition, personal healthcare, agriculture, and other sectors.
A biotechnology company developing phage therapies for treating bacterial infections.
Gamida Cell is a biotechnology company developing cell therapies for treating cancer and hematologic diseases.
A biopharmaceutical company discovering and developing small molecules that target G protein-coupled receptors
Theradiag is a France-based medical diagnostics company developing tracker kits and biotherapy monitoring kits.
Erytech Pharma is a Philadelphia County, Pennsylvania-based company.
Emulation and Verification Engineering is a semiconductor company.
Arnaud-Guilhem le Ribault
Head of Accounting
Founder and Chairman